For evaluating an arm hematoma, should a non-contrast computed tomography (CT) scan be performed rather than a contrast-enhanced CT?

CT for Arm Hematoma: Non-Contrast is Preferred

For evaluating an arm hematoma, perform a non-contrast CT scan rather than contrast-enhanced CT. Non-contrast CT is sufficient to confirm the presence of a hematoma, determine its size and location, and assess its acuity based on attenuation values—all the critical information needed for clinical management.

Rationale Based on Evidence

Why Non-Contrast CT is Adequate

Blood is inherently hyperdense on CT imaging, making hematomas readily visible without contrast administration. According to ACR Appropriateness Criteria for bleeding evaluation, non-contrast CT can expeditiously confirm or exclude bleeding and is particularly helpful when there are concerns about contrast load or renal function 1.

Key advantages of non-contrast CT for hematoma evaluation:

• Attenuation characteristics reveal timing: High attenuation (>50 HU) indicates acute bleeding, mixed attenuation suggests subacute bleeding or rebleeding, and low attenuation indicates chronic blood products 1
• Rapid acquisition: No delay for contrast administration or arterial timing
• Avoids contrast risks: No nephrotoxicity concerns, allergic reactions, or extravasation risk
• Cost-effective: Single-phase imaging reduces radiation exposure and examination time

When Contrast May Be Considered

Add contrast-enhanced imaging (CTA) only if you suspect active arterial bleeding requiring intervention or need to identify a vascular source (pseudoaneurysm, arteriovenous fistula) that might require embolization 1, 2.

Specific scenarios warranting contrast:

• Hemodynamic instability with suspected ongoing arterial hemorrhage
• Expanding hematoma on clinical examination suggesting active bleeding
• Post-procedural complications where vascular injury is suspected
• Pre-intervention planning if angiography/embolization is being considered

CTA can detect active bleeding at rates as low as 0.3 mL/min with sensitivity of approximately 60% and can identify contrast extravasation ("blush") indicating active hemorrhage 1.

Clinical Algorithm

For simple arm hematoma evaluation:

1. Start with non-contrast CT of the affected extremity
2. Assess hematoma size, location, and attenuation (acute vs. chronic)
3. Look for associated fractures or soft tissue injuries
4. Document any mass effect on neurovascular structures

Upgrade to CTA if:

• Patient is hemodynamically unstable
• Hematoma is rapidly expanding on serial examinations
• Diminished distal pulses suggest vascular compromise 2
• Planning interventional procedure (embolization)

Important Caveats

Avoid the pitfall of reflexively ordering contrast "just to be thorough." Research demonstrates that in the vast majority of bleeding cases, non-contrast CT provides sufficient diagnostic information, and contrast adds unnecessary radiation exposure (approximately 40% additional dose), cost, and risk 3.

In patients with renal insufficiency or contrast allergies, non-contrast CT is definitively appropriate and should be the only study performed unless there is compelling evidence of active arterial bleeding requiring immediate intervention 1.

The evidence from multiple ACR guidelines consistently supports that non-contrast CT alone is appropriate for hematoma confirmation and characterization, reserving contrast-enhanced studies for specific clinical scenarios where active bleeding detection or vascular mapping is essential for management decisions 1.